REFERENCES
- Akhmedkhanov A., Toniolo P., Zeleniuch-Jacquotte A., Koenig K., shore R (2002) Br. J. Cancer, 87(11), 1337–1338.
- Baigent C., Blackwell L., Collins R., Emberson J., Godwin J., Peto R., Buring J., Hennekens C., Kearney P., Meade T., Patrono C., Roncaglioni M., Zanchetti A. (2009) Lancet, 373(9678), 1849–1860.
- Baron J., Cole B., Sandler R., Haile R., Ahnen D., Bresalier R., McKeown-Eyssen G., Summers R., Rothstein R., Burke C., Snover D., Church T., Allen J., Beach M., Beck G., Bond J., Byers T., Greenberg E., Mandel J., Marcon N., Mott L., Pearson L., Saibil F., van Stolk R. (2003) N. Engl. J. Med., 348(10), 891–899.
- Bosetti C., Talamini R.; Franceschi S., Negri E., Garavello W., La Vecchia C. (2003) Br. J. Cancer, 88(5), 672–674.
- Chan A., Giovannucci E., Schernhammer E., Colditz G., Hunter D., Willett W., Fuchs C. (2004) Ann. Intern. Med., 140(3), 157–166.
- Chan A., Giovannucci E., Meyerhardt J., Schernhammer E., Curhan G., Fuchs C. (2005) JAMA, 294(8), 914–923.
- Claxton A., Cramer J., Pierce C. (2001) Clin. Ther., 23, 1296–1310.
- Mccann S., Baker J., Reid M., Natarajan N., Moysich K. (2006) Int. J. Cancer, 119(1), 202–207.
- Moysich K., Menezes R., Ronsani A., swede H., Reid M., Cummings K., Falkner K., Loewen G., Bepler G. (2002) BMC Cancer, 2, 31.
- portier H., Filipecki J., weber P., Goldfar G.Lethuaired D., Chauvin J.P. (2002) J. Antimicrob. Chemoth., 49, 337–344.
- Shargel L., pong-Wu S., Yu A. (2004) Applied Biopharmaceutics and Pharmacokinetics, 5th Ed., McGrau-Hill, Medical Publishing Division, pp. 515–551.
- Thun M., Namboodiri M., Heath C. (1991) N. Engl. J. Med., 325(23), 1593–1596.
- Wal P., Wal A., Awani K., Ashutoch S. (2009) J. Pharm. Sci. Technol., 1(2), 59–62.